Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -29.35% is 68% above its 5-year average of -92.13%, near the high end of its 5-year range (-205.05%–-22.05%).
24.47% above its 12-month average of -38.86%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -67.96%.
OPERATING MARGIN
-29.35%
OPERATING MARGIN AVG TTM
-38.86%
OPERATING MARGIN AVG 3Y
-49.73%
OPERATING MARGIN AVG 5Y
-92.13%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+24.47%
CURRENT VS 3Y AVG
+40.98%
CURRENT VS 5Y AVG
+68.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
NEXGEL, Inc.
Market Cap
$1.43M
Operating Margin
-29.35%
TTM Avg
-38.86%
3Y Avg
-49.73%
5Y Avg
-92.13%
Market Cap
$1.43M
Operating Margin
-78.72%
TTM Avg
-104.88%
3Y Avg
-431.56%
5Y Avg
-397.22%
Market Cap
$1.41M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.48M
Operating Margin
-1250.11%
TTM Avg
-662.88%
3Y Avg
-389.78%
5Y Avg
-16081.34%
Market Cap
$1.50M
Operating Margin
-348.43%
TTM Avg
-378.38%
3Y Avg
-440.18%
5Y Avg
-397.59%
Market Cap
$1.64M
Operating Margin
-5936.95%
TTM Avg
-6231.69%
3Y Avg
-5710.52%
5Y Avg
-4448.84%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.43M | -29.35% | -38.86% | -49.73% | -92.13% |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | -78.72% | -104.88% | -431.56% | -397.22% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.48M | -1250.11% | -662.88% | -389.78% | -16081.34% |
| Curis, Inc. (CRIS)vs › | $1.50M | -348.43% | -378.38% | -440.18% | -397.59% |
| Genprex, Inc. (GNPX)vs › | $1.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -5936.95% | -6231.69% | -5710.52% | -4448.84% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.21M | -40873.19% | -20436.60% | -10586.14% | -7186.89% |
Gross Margin
35.1%
Operating Margin
-29.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -67.96% |
| 2026-03-31 | -36.15% |
| 2025-12-31 | -43.42% |
| 2025-09-30 | -24.71% |
| 2025-06-30 | -22.05% |
| 2025-03-31 | -27.69% |
| 2024-12-31 | -27.66% |
| 2024-09-30 | -26.80% |
| 2024-06-30 | -73.19% |
| 2024-03-31 | -68.80% |
| 2023-12-31 | -112.66% |
| 2023-09-30 | -50.12% |
| 2023-06-30 | -65.30% |
| 2023-03-31 | -142.42% |
| 2022-12-31 | -149.05% |
| 2022-09-30 | -182.57% |
| 2022-06-30 | -127.99% |
| 2022-03-31 | -205.05% |
| 2021-12-31 | -166.42% |
| 2021-09-30 | -182.09% |
| 2021-06-30 | -132.61% |
| 2021-03-31 | -194.76% |
| 2020-12-31 | -669.31% |
| 2020-09-30 | -221.07% |
| 2020-06-30 | -593.41% |
| 2020-03-31 | -212.08% |
| 2019-12-31 | -177.84% |
| 2019-09-30 | 25.78% |
| 2019-06-30 | -858.40% |
| 2019-03-31 | -474.42% |
| 2018-12-31 | -119.96% |
| 2018-09-30 | -216.67% |
| 2018-06-30 | -33.22% |
| 2018-03-31 | -68.33% |
| 2017-12-31 | -29.91% |
